เทคโนโลยี เฮลธแคร 1 หนังสือชี้ชวนสวนขอมูลกองทุนรวม กองทุนเปด ทิสโก ไบโอเทคโนโลยี เฮลธแคร (TISCO Biotechnology Healthcare Fund: TBIOTECH) คําเตือน : * กองทุนเปิด ทิสโก้ ไบโอเทคโนโลยี เฮลธ์แคร์ เป็นกอง
/THBEV /TISCO /TISCO-BANK /TK /TLT /TMB /TPIPL /TU /TUC /WHA /YUANTA /TRUE /ABC /ABQK /BOC /CBQK /CCB /ICBC /KCBK /MASQ /UOB SG / ตั๋วแลกเงินอาวัลโดยธนาคารพาณิชย์ หรือเงินฝากต่างประเทศ และ/หรืออาจพิจารณาลง
TISCOTH หนังสือชี้ชวนส่วนข้อมูลกองทุนรวม กองทุนเปิด ทิสโก้ ไบโอเทคโนโลยี เฮลธ์แคร ์ 1 หนังสือช้ีชวนส่วนข้อมูลกองทุนรวม กองทุนเปิด ทิสโก้ ไบโอเทคโนโลยี เฮลธ์แคร์ (TISCO Biotechnology Healthcare Fund
materially affected, or could materially affect, the company’s operations. Also disclose any significant components of revenues and expenses that are necessary to understand the issuer’s results of operations
component of revenue or expenses necessary to understand the issuer's results of operations. 2. To the extent that the financial statements disclose material changes in net sales or revenues, provide a
of 2019, KBank continued to prioritize upgrades of our capability in data compilation and analytics. This will allow us to understand and anticipate each individual customer’s needs under the “Segment
” concept. All of these endeavors aim to understand and anticipate each individual customer’s needs under the “Segment of One” concept, and to provide smart, personalized financial and life solutions to the
concerning the capital market products set out in item 3.2.1(1). 1 The product contains specific features that are complex and are likely to be difficult for investors to understand and to assess the product’s
-ร่าง- (UNOFFICIAL TRANSLATION) Codified up to No. 5 As of 28 November 2018 Readers should be aware that only the original Thai text has legal force, and that this English translation is strictly for reference. Notification of the Capital Market Supervisory Board No. Tor Jor. 39/2559 Re: Application for Approval and Granting of Approval for Offering of Newly Issued Shares _____________________ By virtue of Section 16/6 and Section 89/27 of the Securities and Exchange Act B.E. 2535 (1992), as ame...
Alpha, Beta, and Now…Gamma David Blanchett, CFA, CFP® Head of Retirement Research Morningstar Investment Management Paul Kaplan, Ph.D., CFA Director of Research Morningstar Canada August 28, 2013 Morningstar Investment Management Page 2 of 27©2013 Morningstar. All rights reserved. This document includes proprietary material of Morningstar. Reproduction, transcription or other use, by any means, in whole or in part, without the prior written consent of Morningstar is prohibited. The Morningstar I...